美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA214420"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
72162-2120-1 72162-2120 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20230915 N/A ANDA ANDA214420 Bryant Ranch Prepack POTASSIUM CITRATE 10 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2120-1)
72162-2121-1 72162-2121 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20230918 N/A ANDA ANDA214420 Bryant Ranch Prepack POTASSIUM CITRATE 15 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2121-1)
72162-2122-1 72162-2122 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20230918 N/A ANDA ANDA214420 Bryant Ranch Prepack POTASSIUM CITRATE 5 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2122-1)
72865-191-01 72865-191 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210225 N/A ANDA ANDA214420 XLCare Pharmaceuticals, Inc. POTASSIUM CITRATE 5 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-191-01)
72865-192-01 72865-192 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210225 N/A ANDA ANDA214420 XLCare Pharmaceuticals, Inc. POTASSIUM CITRATE 10 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-192-01)
72865-193-01 72865-193 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210225 N/A ANDA ANDA214420 XLCare Pharmaceuticals, Inc. POTASSIUM CITRATE 15 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-193-01)
31722-129-01 31722-129 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Camber Pharmaceuticals, Inc POTASSIUM CITRATE 5 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-129-01)
31722-130-01 31722-130 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Camber Pharmaceuticals, Inc POTASSIUM CITRATE 10 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-130-01)
31722-132-01 31722-132 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Camber Pharmaceuticals, Inc POTASSIUM CITRATE 15 meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-132-01)
43602-399-05 43602-399 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 5 meq/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-399-05)
43602-399-30 43602-399 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 5 meq/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-399-30)
43602-400-05 43602-400 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 10 meq/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-400-05)
43602-400-30 43602-400 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 10 meq/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-400-30)
43602-401-05 43602-401 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 15 meq/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-401-05)
43602-401-30 43602-401 HUMAN PRESCRIPTION DRUG POTASSIUM CITRATE Potassium Citrate TABLET, EXTENDED RELEASE ORAL 20210215 N/A ANDA ANDA214420 Ascent Pharmaceuticals Inc POTASSIUM CITRATE 15 meq/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-401-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase